BMS-188797
Term · Oncology and biomedicine · MLC-T-ONC-001144
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called taxane analogs.
An analog of paclitaxel with antineoplastic activity. BMS-188797 binds to and stabilizes the resulting microtubules, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and apoptosis. (NCI)
| Identifier | MLC-T-ONC-001144 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001144",
"term": "BMS-188797",
"field": "Oncology and biomedicine",
"definitions": [
"A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called taxane analogs.",
"An analog of paclitaxel with antineoplastic activity. BMS-188797 binds to and stabilizes the resulting microtubules, thereby inhibiting microtubule disassembly which results in cell- cycle arrest at the G2/M phase and apoptosis. (NCI)"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bms-188797/"
}
Record 3,695 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.